Barinthus Biotherapeutics PLC Sponsored ADR (BRNS)
(Delayed Data from NSDQ)
$1.20 USD
0.00 (0.00%)
Updated Sep 26, 2024 03:22 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$5.50 | $9.50 | $3.00 | 358.33% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Barinthus Biotherapeutics PLC Sponsored ADR comes to $5.50. The forecasts range from a low of $3.00 to a high of $9.50. The average price target represents an increase of 358.33% from the last closing price of $1.20.
Analyst Price Targets (5 )
Broker Rating
Barinthus Biotherapeutics PLC Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.33 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, five are Strong Buy, representing 83.33% of all recommendations. A month ago, Strong Buy represented 83.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/12/2024 | H.C. Wainwright & Co. | Yi Chen | Strong Buy | Strong Buy |
6/7/2024 | William Blair | Andy T Hsieh | Strong Buy | Strong Buy |
5/20/2024 | Alliance Global Partners | James Molloy | Strong Buy | Strong Buy |
3/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.33 |
ABR (Last week) | 1.33 |
# of Recs in ABR | 6 |
Average Target Price | $5.50 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 84 of 253 |
Current Quarter EPS Est: | -0.45 |
BRNS FAQs
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) is $5.50. The current on short-term price targets is based on 2 reports.
The forecasts for Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) range from a low of $3 to a high of $9.5. The average price target represents a increase of $358.33 from the last closing price of $1.20.
The current UPSIDE for Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) is 358.33%
Based on short-term price targets offered by five analysts, the average price target for Barinthus Biotherapeutics PLC Sponsored ADR comes to $5.50. The forecasts range from a low of $3.00 to a high of $9.50. The average price target represents an increase of 358.33% from the last closing price of $1.20.